Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Telogen effluvium most affects quality of life in alopecia patients.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Hair transplantation improves life quality and self-esteem in men with male pattern baldness.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Androgenetic alopecia significantly lowers self-esteem and affects social interactions.

Personality traits and anxiety affect hair loss patients' quality of life.

High-intensity phototechnology, especially with other treatments, effectively improves quality of life for diffuse alopecia patients.

Finasteride helps hair loss patients' quality of life.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

Apremilast shows promise for several skin conditions but needs more research.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Alopecia significantly impacts mental health and quality of life, requiring psychological support.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.